NORMAPHAR
0833.501.796 · rovalta.com · 22/09/2026
ACTIVE
NORMAPHAR
Financial year 2023 · closed on 31/12/2023
Net result
-101,7 k €
+64.1% YoY
Gross margin
-6,6 k €
+71.8% YoY
Equity
-62 k €
-256.3% YoY
Overview
What does NORMAPHAR do?
NORMAPHAR is a Public limited company incorporated in 2011. Its registered office is in Lasne.
Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0833.501.796
Incorporation
02/02/2011
Legal form
Public limited company
Registered office
Rue du Try-Bara 1
1380 Lasne · WallonieSee on map
1380 Lasne · WallonieSee on map
Contributed capital
3 258 874,00 €
Latest accounts
31/12/2023
Available with a Rovalta subscriptionTry for 7 days
Financials
Trend over 13 financial years
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||
| Gross margin | -6,6 k € | +71.8% | -23,4 k € | -102% | 1,3 M € | +1841% | 65,5 k € | -66.8% | 197,3 k € | +323% | -88,3 k € | +84.6% | -572,4 k € | -275% | -152,8 k € | -39323% | -387,5 € | +80.4% | -2 k € | -591% | -285,8 € | +81.4% | -1,5 k € | -62.1% | -950 € |
| EBITDA | -7,8 k € | +87.5% | -61,9 k € | -108% | 734,9 k € | +27180% | -2,7 k € | +99.2% | -347,6 k € | +58.4% | -835,2 k € | +34.9% | -1,3 M € | -305% | -316,8 k € | -42994% | -735 € | +68.3% | -2,3 k € | -267% | -633,3 € | +66.5% | -1,9 k € | -44.9% | -1,3 k € |
| Operating result | -100,8 k € | +64.2% | -281,8 k € | -138% | 734,9 k € | +467% | -200,3 k € | +50.5% | -404,9 k € | +53.5% | -870,3 k € | +33.9% | -1,3 M € | -276% | -350,7 k € | -4887% | -7 k € | -18.5% | -5,9 k € | -39.8% | -4,2 k € | +0.1% | -4,2 k € | -68.2% | -2,5 k € |
| Net result | -101,7 k € | +64.1% | -283,5 k € | -139% | 727,7 k € | +214% | -636,8 k € | -52.8% | -416,8 k € | +54.0% | -905 k € | +31.9% | -1,3 M € | -278% | -351,7 k € | -4721% | -7,3 k € | -20.8% | -6 k € | -39.1% | -4,3 k € | +0.1% | -4,3 k € | -71.9% | -2,5 k € |
| Balance sheet | |||||||||||||||||||||||||
| Equity | -62 k € | -256% | 39,7 k € | -87.7% | 323,2 k € | +611% | 45,4 k € | -93.3% | 682,3 k € | +56.5% | 435,9 k € | +267% | -260,5 k € | -124% | 1,1 M € | +7863% | -13,8 k € | -28.0% | -10,8 k € | -128% | -4,7 k € | -1169% | -371,4 € | -109% | 4 k € |
| Total assets | 26 k € | -78.8% | 122,7 k € | -70.7% | 419,4 k € | -44.8% | 759,2 k € | -57.9% | 1,8 M € | -5.7% | 1,9 M € | +57.5% | 1,2 M € | -13.5% | 1,4 M € | +7655% | 18,1 k € | +123% | 8,1 k € | -37.1% | 12,9 k € | +56.5% | 8,3 k € | +65.3% | 5 k € |
| Cash | 150,2 € | -69.9% | 499,1 € | -98.8% | 43,2 k € | – | 64,9 k € | +3863% | 1,6 k € | -96.1% | 41,7 k € | -95.3% | 891,5 k € | +135176% | 659 € | -24.5% | 873 € | -57.5% | 2,1 k € | +6417% | 31,5 € | -66.8% | 94,9 € | ||
| Debts | 38 k € | +15.1% | 33 k € | -65.7% | 96,2 k € | -86.5% | 713,8 k € | -32.7% | 1,1 M € | -28.2% | 1,5 M € | +0.1% | 1,5 M € | +340% | 334,9 k € | +952% | 31,8 k € | +68.7% | 18,9 k € | +7.1% | 17,6 k € | +104% | 8,6 k € | +746% | 1 k € |
| Other | |||||||||||||||||||||||||
| Workforce | – | 0,3 ETP | -70.0% | 1,0 ETP | -58.3% | 2,4 ETP | -63.1% | 6,5 ETP | -33.0% | 9,7 ETP | +2.1% | 9,5 ETP | +280% | 2,5 ETP | – | – | – | – | – | ||||||
Estimate
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
See the valuationGovernance
Board of directors
Seen on filing of 31/12/2023 · 5 active · 24 ended
At this address
Other companies at this address
| Company | CBE no. |
|---|---|
ILOTVERT● Active | 0635.825.892 |
MelanieS● Active | 1020.629.347 |
| 0739.780.495 | |
Smart Alternative● Active | 0717.607.879 |
Financials
Annual accounts
Full financial information
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 | 01/01/2018 |
| Closing of the financial year | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 | 31/12/2018 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 31/12/2024 | 31/08/2023 | 30/08/2022 | 12/08/2021 | 17/07/2020 | 14/08/2019 |
| General meeting | 28/06/2024 | 13/07/2023 | 10/06/2022 | 11/06/2021 | 12/06/2020 | 28/06/2019 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Ratios
Financial ratios
Looking for more information about this company?
Try for 7 daysFilings
Annual accounts filings
13 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2023 | 28/06/2024 | 31/12/2024 | French | |
| Abridged model | 31/12/2022 | 13/07/2023 | 31/08/2023 | French | |
| Abridged model | 31/12/2021 | 10/06/2022 | 30/08/2022 | French | |
| Abridged model | 31/12/2020 | 11/06/2021 | 12/08/2021 | French | |
| Abridged model | 31/12/2019 | 12/06/2020 | 17/07/2020 | French | |
| Abridged model | 31/12/2018 | 28/06/2019 | 14/08/2019 | French | |
| Abridged model | 31/12/2017 | 08/06/2018 | 17/07/2018 | French | |
| Abridged model | 31/12/2016 | 09/06/2017 | 02/08/2017 | French | |
| Abridged model | 31/12/2015 | 10/06/2016 | 29/07/2016 | French | |
| Abridged model | 31/12/2014 | 12/06/2015 | 28/07/2015 | French | |
| Abridged model | 31/12/2013 | 30/06/2014 | 23/07/2014 | French | |
| Abridged model | 31/12/2012 | 14/06/2013 | 05/07/2013 | French | |
| Abridged model | 31/12/2011 | 30/06/2012 | 25/09/2012 | French |
Valuation
Estimate
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Governance
Board of directors
Seen on filing of 31/12/2023 · 5 active · 24 ended
Shareholders
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette
Belgian Official Gazette publications
- Mandates23/02/2024DEMISSIONS, NOMINATIONS
- Mandates05/05/2021STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
- Registered office09/12/2020SIEGE SOCIAL
- Mandates20/06/2019STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
- Mandates11/05/2018STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - SIEGE SOCIAL - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
- Registered office28/10/2016SIEGE SOCIAL
- Capital / shares25/07/2016CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
- Mandates03/03/2016DENOMINATION - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE
Source: Belgian Official Gazette
Similar companies
Competition
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2023Annual accounts 2023-101,7 k €↑
- 2022Annual accounts 2022-283,5 k €↓
- 2021Annual accounts 2021727,7 k €↑
- 2020Annual accounts 2020-636,8 k €↓
- 2019Annual accounts 2019-416,8 k €↑
- 2018Annual accounts 2018-905 k €↑
- 2017Annual accounts 2017-1,3 M €↓
- 2016Annual accounts 2016-351,7 k €↓
- 2015Annual accounts 2015-7,3 k €↓
- 2015Name changeNORMAPHAR
- 2014Annual accounts 2014-6 k €↓
- 2013Annual accounts 2013-4,3 k €↑
- 2012Annual accounts 2012-4,3 k €↓
- 2011Annual accounts 2011-2,5 k €
- 02/02/2011IncorporationPublic limited company
- 2011Name changeCOMPAGNIE DES BREVETS NUTRACEUTIQUES